REG - Amati AIM VCT PLC - Issue of Equity

Amati AIM VCTAnnouncement

14/01/2020 10:40

RNS Number : 7473Z
Amati AIM VCT PLC
14 January 2020
 


 
Amati AIM VCT plc (the "Company")
Legal Entity Identifier: 213800HAEDBBK9RWCD25
 
Offer for Subscription of New Shares (the "Offer")
 
Amati AIM VCT plc announces an allotment on 13 January 2020 of 1,996,377 New Shares pursuant to the Offer. In accordance with the Terms and Conditions of the Offer, the Offer Price at which new ordinary shares were allotted, which was calculated by reference to the net asset value of an ordinary share on 9 January 2020, was 156.72p per ordinary share (net asset value divided by 0.99 to allow for issue costs of 1.0%).
 
Following the allotment above, the total number of ordinary shares in issue is 94,150,096 with each ordinary share carrying one voting right. That figure may be used by shareholders as the denominator for the calculation to determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules. 
 
Applications have been made for the New Shares to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for admission to trading on the Main Market. It is expected that admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer on or around 17 January 2020.  CREST accounts are expected to be credited within five business days of allotment and definitive documents of title are expected to be dispatched within ten business days of allotment.
 
Terms defined in the Prospectus published by the Company on 31 October 2019 have the same meanings in this announcement unless the context requires otherwise.
 
 
For further information please contact Doreen Nic on 0131 243 7215 or email info@amatiglobal.com.
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEKKQBNKBKDODD